Skip to main content

Areas of interest

We build on our internal expertise, transforming breakthrough science into effective medicine.

Our key focus areas


As leading experts in autoimmune diseases and therapies, AbbVie is focused on developing new medicines to address chronic progressive diseases in the field of immunology. Our programs focus on investigating both targeted oral therapies and biologics. Our areas of interest include:

  • Gastroenterology (Crohn’s disease, ulcerative colitis)
  • Dermatology (psoriasis, atopic dermatitis, hidradentis suppurativa)
  • Rheumatology (RA, PsA, AS, GCA, PMR)
  • Innate immunity / interferon and TH2 mediated diseases (SLE, systemic sclerosis, Sjögren’s syndrome, DM, eosinophilic diseases)
  • Select fibrotic conditions (systemic sclerosis, IPF)


Our goal is to transform the way cancer is treated. AbbVie is committed to discovering and developing therapies that work against the processes that cancer cells need to survive. We are committed to achieving long-term control of hematologic malignancies, and investing to identify and advance promising therapies for solid tumors. Our areas of interest include:

  • Novel and differentiated programs directed towards enhanced tumor cell targeting, oncogenic signaling pathways and immuno-oncology
  • Targeted biologics and next generation cell therapies
  • Novel approaches to small molecules, including technologies to address hard-to-drug  target classes


Our commitment to preserving the personhood of those living with neurological and psychiatric disorders is unwavering. AbbVie Neuroscience portfolio consists of approved therapies and a robust pipeline in neurological and psychiatric disorders with high unmet need. Our areas of interest include:

  • Disease modification approaches for neurodegenerative diseases, including Alzheimer’s and Parkinson’s disease, and select diseases driven by shared biological pathways
  • Psychiatric diseases, including  bipolar disorder, bipolar depression, major depressive disorder, generalized anxiety disorder and schizophrenia
  • Symptomatic approaches with clinical validation for cognitive and neurobehavioral deficits in Alzheimer’s and Parkinson’s disease
  • Migraine
  • Spasticity and movement disorders; neurorestoration in multiple sclerosis

Eye Care

Our mission in eye care remains to protect and preserve vision for a better quality of life for the millions of people who experience vision loss every year. AbbVie continues to search for new therapeutics that address unmet needs and new approaches to retina-related diseases, glaucoma, dry eye disease, and refractive conditions. We are focused on both biologics and small molecules, as well as next generation drug delivery technologies. Our areas of interest include:

  • Retinal degeneration, including Dry AMD/geographic atrophy, Wet AMD and diabetic retinal diseases
  • Dry eye and ocular surface disease of various etiologies
  • Glaucoma, addressing intraocular pressure control and neuroprotection
  • Refractive medicine, including presbyopia, myopia and corneal dystrophies


Allergan Aesthetics is developing a portfolio of innovative products in the areas of facial and body filling, breast reconstruction/augmentation, and regenerative soft tissue repair. We are interested in strategic collaborations that broaden our understanding of the aging process, and therapeutic  targets to address the natural, physical, and biological changes that occur with age. We seek out and partner with strategic collaborators for neurotoxins, dermal fillers, body aesthetics, plastic surgery and regenerative medicine, hair growth, and skin care. We are also interested in exploring the use of energy-based devices for the field of body aesthetics. Cell and gene therapies with a focus on extracellular matrix components including collagen and elastin are also of interest. Our areas of interest include:

  • Dermal injectables for skin and tissue
  • Plastics and regenerative medicine
  • Toxins for aesthetic and therapeutics
  • Hair growth
  • Body contouring and fat reduction
  • Topical skin care

Additional focus areas

We also selectively focus our attention on other areas where there is unmet need:

  • Virology
  • Cystic fibrosis
  • Women’s health
  • Platforms and technologies


For more information about partnering with AbbVie, download our brochure.